Article Sidebar
Views pdf: 0
EVALUATION OF THE SAFETY AND FEASIBILITY OF PERCUTANEOUS CARDIOPULMONARY BYPASS IN MINIMALLY INVASIVE CARDIAC SURGERY
Main Article Content
Abstract
Objective: To evaluate the safety and feasibility of percutaneous femoral artery–vein cannulation for cardiopulmonary bypass (CPB) in minimally invasive cardiac surgery (MICS). Patients and Methods: A retrospective review of 40 MICS cases with percutaneous femoral cannulation for CPB at the University Medical Center Ho Chi Minh City (April 2024–June 2025). Results: The mean common femoral artery diameter was 7.8 ± 1.1 mm; 5% had mild atherosclerosis. Most patients underwent mitral valve repair or replacement (62.5%).The mean time from puncture to CPB initiation was 36.2 ± 10.0 minutes; CPB duration 139.7 ± 36.4 minutes; aortic cross-clamp time 93.9 ± 33.6 minutes. Complications included one open femoral cut-down, one femoral artery thrombosis. There were no cases of postoperative fluid collection, limb ischemia, compartment syndrome, or infection. Pre-discharge duplex ultrasound showed triphasic waveforms in all common femoral arteries, unchanged from preoperative findings. Conclusion: Percutaneous femoral cannulation for CPB in MICS is feasible, safe, and effective.
Article Details
Keywords
percutaneous cardiopulmonary bypass, femoral artery–vein cannulation, minimally invasive cardiac surgery
References
2. Taramasso M, Benussi S, Pappalardo F, et al. Percutaneous versus surgical femoral cannulation in minimally invasive cardiac surgery: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg. 2022;34(4):683–691. doi:10.1093/icvts/ivab348
5. Nishijima T, Ushijima T, Fuke Y, Kan‑O M, Kimura S, Sonoda H, Shiose A. Cannula to femoral artery diameter ratio predicts potential lower‑limb ischemia in minimally invasive cardiac surgery with femoral cannulation. Innovations (Phila). 2024;19(2): 161–168. doi:10.1177/ 15569845241237212
4. Biancari F, Perrotti A, Dahlbacka S, et al. Outcome of percutaneous femoral cannulation for cardiopulmonary bypass in cardiac surgery. Perfusion. 2019;34(5): 353–359. doi:10.1177/ 0267659119832093
5. AmSECT (American Society of Extracorporeal Technology). Guidelines for Perfusion Practice. J Extra Corpor Technol. 2013; 45(3):156–166.
6. Glauber M, Miceli A, Canarutto D, et al. Port-access minimally invasive cardiac surgery: cannulation, cardiopulmonary bypass management and myocardial protection. Ann Cardiothorac Surg. 2015;4(1): 44–52. doi:10. 3978/j.issn.2225-319X.2014.11.04
7. Nishimura T, Fukuda S, Yamamoto Y, et al. Efficacy and safety of percutaneous femoral cannulation with ProGlide preclosure technique in minimally invasive cardiac surgery. Gen Thorac Cardiovasc Surg. 2023;71(2): 191–197. doi:10. 1007/s11748-022-01877-3
8. Nguyễn Hoàng Định, Bùi Đức An Vinh, Nguyễn Ngô Gia Phúc, Lang Minh Triết, Hoàng Huân, Phan Quang Thuận. Biến chứng ngoại vi do tuần hoàn ngoài cơ thể trên động tĩnh mạch đùi sau phẫu thuật van hai lá ít xâm lấn. Hue J Med Pharm Sci.2024;14(1):DOI:10.34071/ jmp.2024.1.3.